Morgan Stanley Capital Partners

Canaccord Genuity Advises Morgan Stanley Capital Partners on its Investment in Digital Healthcare Education Company US HealthConnect

​​​Canaccord Genuity is pleased to announce it has advised investment funds managed by Morgan Stanley Capital Partners, a Private Equity team within Morgan Stanley Investment Management, on its investment in US HealthConnect, Inc.,(“USHC”) the worldwide leader in digital education strategies and engagement data solutions for pharmaceutical, biotech, and medical diagnostic and device companies. Morgan Stanley Capital Partners is partnering with the current management team led by Frank Russomano, who will remain President and CEO and continue to drive platform expansion during the investment.

US HealthConnect is a pioneering digital platform providing pharma-sponsored continuing medical education and promotional education to healthcare providers. Founded in 1999, the company has evolved into an industry leader in digital medical education focusing on diversified areas, such as oncology, cardiology, and women’s health. USHC uses its unique, data-driven strategic and consultative approach to help pharmaceutical clients meet the information needs of healthcare providers. USHC’s companies include ReachMD, Global Learning Collaborative, Prova Education, Omnia Education, Medtelligence, Kynectiv, Winding River Productions, Connect Healthcare Communications, and AGILE.

Morgan Stanley Capital Partners, the middle-market focused private equity business of Morgan Stanley Investment Management, has invested capital in a broad spectrum of industries for over two decades. Morgan Stanley Capital Partners focuses on privately negotiated equity and equity-related investments in North America and seeks to create value in portfolio companies primarily through operational improvement.

Canaccord Genuity, with a team led by Tom O’Connor, served as exclusive financial advisor to Morgan Stanley Capital Partners.
​​​​​​​